Eli Lilly Receives Subpoena Over Zyprexa
The company said Friday that it received the subpoena in September, according to a filing with the U.S. Securities and Exchange Commission. The attorney general requested information related to the company’s marketing and sale of Zyprexa, and its status on the state’s formulary.
U.K. drug company AstraZeneca was handed a similar subpoena last week from the California attorney general over...
To view the full article, register now.